Yesterday, April 4, 2016, 48 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $300.52 to $2,835,525.00.

Highlighted Stocks Traded by Insiders:

Inogen (INGN) - FREE Research Report

Bauerlein Alison, who is EVP, Finance & CFO at Inogen, sold 4,360 shares at $44.33 on April 4, 2016. Following this transaction, the EVP, Finance & CFO owned 47,610 shares meaning that the stake was reduced by 8.39% with the 4,360-share transaction.

The shares most recently traded at $44.89, up $0.56, or 1.24% since the insider transaction. Historical insider transactions for Inogen go as follows:

  • 4-Week # shares sold: 6,920
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 6,920
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 11,920

The average volume for Inogen has been 208,000 shares per day over the past 30 days. Inogen has a market cap of $892.6 million and is part of the health care sector and health services industry. Shares are up 11.6% year-to-date as of the close of trading on Monday.

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has a P/E ratio of 80.3. Currently, there are 5 analysts who rate Inogen a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on INGN - FREE

TheStreet Quant Ratings

rates Inogen as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the stock itself is trading at a premium valuation. Get the full

Inogen Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hydrogenics (HYGS) - FREE Research Report

CommScope, Inc. of North Carolina, who is 10% Owner at Hydrogenics, sold 6,729 shares at $8.16 on April 4, 2016. Following this transaction, the 10% Owner owned 1.3 million shares meaning that the stake was reduced by 0.52% with the 6,729-share transaction.

The shares most recently traded at $7.90, down $0.26, or 3.25% since the insider transaction. Historical insider transactions for Hydrogenics go as follows:

  • 4-Week # shares sold: 28,387
  • 12-Week # shares sold: 44,536
  • 24-Week # shares sold: 44,536

The average volume for Hydrogenics has been 57,600 shares per day over the past 30 days. Hydrogenics has a market cap of $101.3 million and is part of the industrial goods sector and industrial industry. Shares are down 7.87% year-to-date as of the close of trading on Monday.

Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane technology. Currently, there are 3 analysts who rate Hydrogenics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HYGS - FREE

TheStreet Quant Ratings

rates Hydrogenics as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Hydrogenics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Dixie Group (DXYN) - FREE Research Report

Blue William F JR, who is Director at Dixie Group, bought 970 shares at $4.28 on April 4, 2016. Following this transaction, the Director owned 3,932 shares meaning that the stake was boosted by 32.75% with the 970-share transaction.

The shares most recently traded at $4.06, down $0.22, or 5.42% since the insider transaction. Historical insider transactions for Dixie Group go as follows:

  • 4-Week # shares bought: 6,000
  • 4-Week # shares sold: 11,242
  • 12-Week # shares bought: 6,000
  • 12-Week # shares sold: 11,242
  • 24-Week # shares bought: 6,000
  • 24-Week # shares sold: 11,242

The average volume for Dixie Group has been 29,700 shares per day over the past 30 days. Dixie Group has a market cap of $67.4 million and is part of the industrial goods sector and industrial industry. Shares are down 18.74% year-to-date as of the close of trading on Friday.

The Dixie Group, Inc. manufactures, markets, and sells carpets and rugs for residential and commercial applications primarily in the United States. Currently, there is 1 analyst who rates Dixie Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DXYN - FREE

TheStreet Quant Ratings

rates Dixie Group as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, generally disappointing historical performance in the stock itself and poor profit margins. Get the full

Dixie Group Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.